Onconetix Inc (ONCO)

Onconetix Inc (ONCO) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $2.5M; returns 1 day +2.8%, 1 week -12.7%, 1 year -99.8%.

Onconetix Inc. is a commercial-stage biotechnology firm focused on oncology and men's health, primarily engaged in developing and commercializing therapeutic and diagnostic solutions for prostate cancer and related prostate conditions.

Groups ONCO belongs to

• Recent Reverse Splits
• Healthcare
• Biotechnology
• Oncology
• Commercial Stage
• Commercial Stage Biotech
• Cancer Therapeutics
• Early Cancer Detection
• Biopharmaceutical
• Health Diagnostics and Imaging

ONCO financial model: income statement, cash flow and balance sheet